Cencora, Inc. (BVMF:C1CO34)

Brazil flag Brazil · Delayed Price · Currency is BRL
890.89
0.00 (0.00%)
At close: Dec 4, 2025
17.53%
Market Cap 356.65B
Revenue (ttm) 1.71T
Net Income (ttm) 8.28B
Shares Out n/a
EPS (ttm) 42.42
PE Ratio 43.06
Forward PE 19.25
Dividend 4.23 (0.48%)
Ex-Dividend Date Nov 13, 2025
Volume 73
Average Volume 17
Open 889.11
Previous Close n/a
Day's Range 889.11 - 890.89
52-Week Range 692.30 - 960.00
Beta 0.64
RSI 58.76
Earnings Date Feb 4, 2026

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, ... [Read more]

Sector Healthcare
Founded 1871
Employees 51,000
Stock Exchange Brazil Stock Exchange
Ticker Symbol C1CO34
Full Company Profile

Financial Performance

In 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.